Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
December 18, 2011
12/20/2011 December 18, 2011
Enlight Biosciences Forms Lucrative New Partnerships Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and...
December 18, 2011
Enlight Biosciences Forms Lucrative New Partnerships December 18, 2011
Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and Novo Nordisk. As partners in Enlight,...
December 11, 2011
12/13/2011 December 11, 2011
Abbott Laboratories Spends $400 Million on Development Deal Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide...
December 4, 2011
12/6/2011 December 4, 2011
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users Nanion's ion channel screening platform, the SyncroPatch 96, has been...
November 27, 2011
11/29/2011 November 27, 2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched...
November 20, 2011
11/22/2011 November 20, 2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life...
November 10, 2011
11/15/2011 November 10, 2011
Lundbeck & Otsuka Enter Long-Term CNS Agreement, Deal Has $1.8-Billion Potential Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S recently...
November 3, 2011
11/8/2011 November 3, 2011
Gateway Analytical Growth Demands Move to a Larger Facility Gateway Analytical recently announced the company will move to a larger...
October 27, 2011
11/01/2011 October 27, 2011
Activartis Develops Cancer Vaccine in Phase II, Seeks Partner Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing...
October 9, 2011
10/11/2011 October 9, 2011
Carticept Medical Receives 510(k) Clearance for Navigator Delivery System Carticept Medical, Inc., a developer of innovative products for the treatment...
October 9, 2011
Zosano Pharma & Asahi Kasei Pharma Enter Agreement for Transdermal Patch for Up to $132.5 Million October 9, 2011
Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation (AKP) recently announced they have entered into a long-term strategic collaboration for...
September 27, 2011
10/4/2011 September 27, 2011
Talon Therapeutics' NDA Accepted for Filing by US FDA Under Subpart H Talon Therapeutics, Inc. recently announced its NDA seeking...
September 18, 2011
9/20/2011 September 18, 2011
Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices Unilife Corporation recently announced the development of its AutoInfusor portfolio...
September 11, 2011
9/13/2011 September 11, 2011
Evotec & Roche to Develop Compound That Could Slow AD Progression Evotec AG and Roche AG recently announced they have...
August 25, 2011
8/30/2011 August 25, 2011
Avantor Performance Materials Expands Portfolio Avantor Performance Materials recently announced it has expanded its portfolio by offering cGMP-manufactured Methylene Chloride...
August 18, 2011
8/23/2011 August 18, 2011
Intellipharmaceutics & Par Pharmaceutical Expand Development & Commercialization Agreement Intellipharmaceutics International Inc. recently announced that they have added the development...
August 18, 2011
Alexza Pharmaceuticals Announces PDUFA Goal Date August 18, 2011
Alexza Pharmaceuticals, Inc. recently announced the US FDA has accepted the ADASUVE NDA as a complete, class 2 response to...
August 11, 2011
8/16/2011 August 11, 2011
Boehringer Ingelheim Licenses ProBioGen's GlymaxX Technology Boehringer Ingelheim and ProBioGen AG recently announced they have signed a non-exclusive Licensing...
August 4, 2011
8/9/2011 August 4, 2011
Celgene & Acceleron Enter Agreement Worth Up to $242 Million Celgene Corporation and Acceleron Pharma, Inc. recently announced they...
July 17, 2011











